Technical Analysis for XBIT - XBiotech Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | -2.50% | |
| MACD Bearish Signal Line Cross | Bearish | 0.35% | |
| Crossed Above 20 DMA | Bullish | 0.35% | |
| Fell Below 20 DMA | Bearish | 3.37% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -0.23% | |
| Earnings Movers | Other | -0.23% | |
| Overbought Stochastic | Strength | -0.23% | |
| Stochastic Reached Overbought | Strength | -7.93% | |
| Earnings Movers | Other | -7.93% | |
| Outside Day | Range Expansion | -7.93% |
| Alert | Time |
|---|---|
| Down 3% | about 11 hours ago |
| Rose Above Previous Day's High | about 14 hours ago |
| Down 2 % | about 14 hours ago |
| Down 1% | about 14 hours ago |
| Up 1% | about 14 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/20/2024
XBiotech is a fully integrated, global biopharmaceutical company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies. XBiotech currently is advancing a pipeline of therapies by harnessing naturally occurring antibodies from patients with immunity to certain diseases. Utilizing natural human immunity as a source of new medicines offers the potential to redefine the standards of care for a wide range of diseases. The discovery and manufacturing techniques which enable this were designed by and are exclusive to XBiotech. Headquartered in Austin, Texas, XBiotech also leads the development of innovative, proprietary manufacturing technology to reduce the cost and complexity of biological drug production.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Disease Immunology Pharmacy Antibodies Medication Antibody Drug Products Immunity Manufacturing Techniques
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Disease Immunology Pharmacy Antibodies Medication Antibody Drug Products Immunity Manufacturing Techniques
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.96 |
| 52 Week Low | 3.51 |
| Average Volume | 81,345 |
| 200-Day Moving Average | 5.46 |
| 50-Day Moving Average | 8.02 |
| 20-Day Moving Average | 8.36 |
| 10-Day Moving Average | 8.73 |
| Average True Range | 0.64 |
| RSI (14) | 52.15 |
| ADX | 23.21 |
| +DI | 18.21 |
| -DI | 14.00 |
| Chandelier Exit (Long, 3 ATRs) | 7.68 |
| Chandelier Exit (Short, 3 ATRs) | 9.42 |
| Upper Bollinger Bands | 9.35 |
| Lower Bollinger Band | 7.37 |
| Percent B (%b) | 0.62 |
| BandWidth | 23.71 |
| MACD Line | 0.18 |
| MACD Signal Line | 0.19 |
| MACD Histogram | -0.0146 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.43 | ||||
| Resistance 3 (R3) | 9.45 | 9.19 | 9.29 | ||
| Resistance 2 (R2) | 9.19 | 8.98 | 9.18 | 9.24 | |
| Resistance 1 (R1) | 8.89 | 8.84 | 8.76 | 8.87 | 9.20 |
| Pivot Point | 8.63 | 8.63 | 8.57 | 8.62 | 8.63 |
| Support 1 (S1) | 8.33 | 8.42 | 8.20 | 8.31 | 7.98 |
| Support 2 (S2) | 8.07 | 8.29 | 8.06 | 7.94 | |
| Support 3 (S3) | 7.77 | 8.07 | 7.89 | ||
| Support 4 (S4) | 7.75 |
